Brief: Gentian Diagnostics Granted Patent In US

Gentian Diagnostics ASA

05/12/2022 10:10

Dec 5 (Reuters) - Gentian Diagnostics ASA  GENT.OL :
    * PATENT GRANTED FOR NT-PROBNP IN THE U.S.
    * NT-PROBNP IS A NON-INVASIVE BIOMARKER FOR DIAGNOSIS OF
CONGESTIVE HEART FAILURE
    * PATENT FOR NT-PROBNP IS ISSUED BY U.S. PATENT AND
TRADEMARK
OFFICE

Source text for Eikon:  ID:nObi1Qmmla 
Further company coverage:  GENT.OL 
 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))